Browse by Phase
Phase 1 / Phase 2 Clinical Trials
Phase 1/2 combined trials evaluate both safety (Phase 1) and preliminary efficacy (Phase 2) in a single study protocol, often used to accelerate early development.
Total Trials
374
Recruiting Now
374
Top Conditions in Phase 1 / Phase 2
NCT06144749 Phase 1, Phase 2
Recruiting
A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Mo...
Condition
Anemia, Sickle Cell
Enrollment
9 pts
Location
Panama
Sponsor
Hillhurst Biopharmaceuticals,
NCT05794425 Phase 1, Phase 2
Recruiting
Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Fail...
Condition
Bone Marrow Failure Disorders
Enrollment
100 pts
Location
China
Sponsor
Shandong Qilu Stem Cells Engin
NCT06726148 Phase 1, Phase 2
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER...
Condition
Advanced HR+/HER2- Breast Cancer
Enrollment
280 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT07203599 Phase 1, Phase 2
Recruiting
A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Co...
Condition
Androgenic Alopecia
Enrollment
59 pts
Location
China
Sponsor
Shenzhen People's Hospital
NCT06708663 Phase 1, Phase 2
Recruiting
HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid Tumours
Condition
Biliary Tract Cancer
Enrollment
124 pts
Location
China
Sponsor
Hangzhou Hanx Biopharmaceutica
NCT06109558 Phase 1, Phase 2
Recruiting
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
Condition
Non Small Cell Lung Cancer
Enrollment
120 pts
Location
China
Sponsor
Hunan Province Tumor Hospital
NCT05985655 Phase 1, Phase 2
Recruiting
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Condition
Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment
230 pts
Location
United States, Belgium, United Kingdom
Sponsor
Exscientia AI Ltd., a wholly o
NCT07180563 Phase 1, Phase 2
Recruiting
Randomized Controlled Trial of Berberine in Combination With Doxycycline in the ...
Condition
Chronic Endometritis
Enrollment
206 pts
Location
China
Sponsor
The Fourth Affiliated Hospital
NCT07414212 Phase 1, Phase 2
Recruiting
Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With ...
Condition
Amyotrophic Lateral Sclerosis
Enrollment
90 pts
Location
Spain
Sponsor
Biogipuzkoa Health Research In
NCT03457493 Phase 1, Phase 2
Recruiting
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's D...
Condition
Parkinson Disease
Enrollment
205 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05617365 Phase 1, Phase 2
Recruiting
Treating Chronic Cervicogenic Head and Neck Pain
Condition
Cervicogenic Headache
Enrollment
30 pts
Location
United States
Sponsor
Michigan State University
NCT05351593 Phase 1, Phase 2
Recruiting
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
Condition
CNS Lymphoma
Enrollment
35 pts
Location
United States
Sponsor
James Rubenstein
NCT07255664 Phase 1, Phase 2
Recruiting
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based ...
Condition
Metastatic Colorectal Cancer
Enrollment
12 pts
Location
Germany
Sponsor
Curacell Holding AB
NCT02584244 Phase 1, Phase 2
Recruiting
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Condition
Colorectal Cancer
Enrollment
66 pts
Location
United States
Sponsor
Lumicell, Inc.
NCT04130516 Phase 1, Phase 2
Recruiting
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801a...
Condition
Solid Tumor, Adult
Enrollment
200 pts
Location
United States
Sponsor
Linnaeus Therapeutics, Inc.
NCT07070232 Phase 1, Phase 2
Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe a...
Condition
Advanced Solid Tumor
Enrollment
980 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
NCT07038096 Phase 1, Phase 2
Recruiting
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Ca...
Condition
Small Cell Lung Cancer
Enrollment
350 pts
Location
China
Sponsor
Suzhou Zelgen Biopharmaceutica
NCT06118086 Phase 1, Phase 2
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid...
Condition
Adenoid Cystic Carcinoma
Enrollment
100 pts
Location
United States, France
Sponsor
Remix Therapeutics
NCT07010120 Phase 1, Phase 2
Recruiting
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic H...
Condition
HNSCC
Enrollment
29 pts
Location
China
Sponsor
West China Hospital
NCT06735170 Phase 1, Phase 2
Recruiting
Tuberoplasty Versus Balloon Spacer
Condition
Rotator Cuff Tears
Enrollment
40 pts
Location
United States
Sponsor
University of Minnesota
NCT07216560 Phase 1, Phase 2
Recruiting
First-in-human Study of 7MW4911 in GI Cancer
Condition
GI Cancers
Enrollment
200 pts
Location
United States
Sponsor
Mabwell (Shanghai) Bioscience
NCT06467318 Phase 1, Phase 2
Recruiting
Does Non-Steroidal Anti-inflammatory Drugs Decrease the Quality of Pleurodesis A...
Condition
Primary and Secondary Spontaneous Pneumothorax
Enrollment
116 pts
Location
Egypt
Sponsor
Ain Shams University
NCT07129382 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Mode...
Condition
Plaque Psoriasis
Enrollment
220 pts
Location
China
Sponsor
Chipscreen Biosciences, Ltd.
NCT05623982 Phase 1, Phase 2
Recruiting
A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin...
Condition
Non-hodgkin's Lymphoma
Enrollment
40 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C
NCT05060627 Phase 1, Phase 2
Recruiting
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relaps...
Condition
Relapsed Multiple Myeloma
Enrollment
60 pts
Location
Spain
Sponsor
PETHEMA Foundation